|
1
|
Leake PA, Cardoso R, Seevaratnam R,
Lourenco L, Helyer L, Mahar A, Law C and Coburn NG: A systematic
review of the accuracy and indications for diagnostic laparoscopy
prior to curative-intent resection of gastric cancer. Gastric
Cancer. 15 (Suppl 1):S38–S47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Afuwape OO, Irabor DO, Ladipo JK and
Ayandipo B: A review of the current profile of gastric cancer
presentation in the university college hospital Ibadan, a tertiary
health care institution in the tropics. J Gastrointest Cancer.
43:177–180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pimenta-Melo AR, Monteiro-Soares M,
Libânio D and Dinis-Ribeiro M: Missing rate for gastric cancer
during upper gastrointestinal endoscopy: A systematic review and
meta-analysis. Eur J Gastroenterol Hepatol. 28:1041–1049. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Veisani Y and Delpisheh A: Survival rate
of gastric cancer in Iran; A systematic review and meta-analysis.
Gastroenterol Hepatol Bed Bench. 9:78–86. 2016.PubMed/NCBI
|
|
5
|
Xia JT, Chen LZ, Jian WH, Wang KB, Yang
YZ, He WL, He YL, Chen D and Li W: MicroRNA-362 induces cell
proliferation and apoptosis resistance in gastric cancer by
activation of NF-κB signaling. J Transl Med. 12:332014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Shi Y, Li X, Du R, Luo G, Xia L,
Du W, Chen B, Zhai H, Wu K and Fan D: Proteasome inhibitor MG132
reverses multidrug resistance of gastric cancer through enhancing
apoptosis and inhibiting P-gp. Cancer Biol Ther. 7:540–546. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dittmar Y, Altendorf-Hofmann A, Rauchfuss
F, Götz M, Scheuerlein H, Jandt K and Settmacher U: Resection of
liver metastases is beneficial in patients with gastric cancer:
Report on 15 cases and review of literature. Gastric Cancer.
15:131–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roberts P, Seevaratnam R, Cardoso R, Law
C, Helyer L and Coburn N: Systematic review of
pancreaticoduodenectomy for locally advanced gastric cancer.
Gastric Cancer. 15 (Suppl 1):S108–S115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li K and Li J: Current molecular targeted
therapy in advanced gastric cancer: A comprehensive review of
therapeutic mechanism, clinical trials, and practical application.
Gastroenterol Res Pract. 2016:41056152016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong XD, Ren X, Cai MY, Yang JW, Liu X
and Yang JM: Long non-coding RNAs: An emerging powerhouse in the
battle between life and death of tumor cells. Drug Resist Updat.
26:28–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu M, Sun W, Liu Y and Dong X: The role
of lncRNA MALAT1 in bone metastasis in patients with non-small cell
lung cancer. Oncol Rep. 36:1679–1685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Z, Wang R, Zhang T and Dong X:
Hypoxia/lncRNA-AK123072/EGFR pathway induced metastasis and
invasion in gastric cancer. Int J Clin Exp Med. 8:19954–19968.
2015.PubMed/NCBI
|
|
13
|
Li J, Zhou D, Wang Z, Tan L, Zhou Y, Li J
and Sheng X: Reversal effect of 5-aza-2-deoxycytidine on the
maternally expressed gene 3 promoter hypermethylation and its
inhibitory effect on the proliferation of epithelial ovarian cancer
cells. Zhonghua Zhong Liu Za Zhi. 37:324–329. 2015.(In Chinese).
PubMed/NCBI
|
|
14
|
Kruer TL, Dougherty SM, Reynolds L, Long
E, de Silva T, Lockwood WW and Clem BF: Expression of the lncRNA
maternally expressed gene 3 (MEG3) contributes to the control of
lung cancer cell proliferation by the Rb pathway. PLoS One.
11:e01663632016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv D, Sun R, Yu Q and Zhang X: The long
non-coding RNA maternally expressed gene 3 activates p53 and is
downregulated in esophageal squamous cell cancer. Tumour Biol. Oct
24–2016.(Epub ahead of print). View Article : Google Scholar
|
|
16
|
Yan-Hua L, Xiang-Lei L, Hong L and
Jian-Jun W: Long noncoding ribonucleic acids maternally expressed
gene 3 inhibits lung cancer tumor progression through
downregulation of MYC. Indian J Cancer. 52 (Suppl 3):E190–E193.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsuoka J, Yashiro M, Doi Y, Fuyuhiro Y,
Kato Y, Shinto O, Noda S, Kashiwagi S, Aomatsu N, Hirakawa T, et
al: Hypoxia stimulates the EMT of gastric cancer cells through
autocrine TGFβ signaling. PLoS One. 8:e623102013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Liu L, Wang Y, Zhao G, Xie R, Liu
C, Xiao X, Wu K, Nie Y, Zhang H and Fan D: KLF8 involves in
TGF-beta-induced EMT and promotes invasion and migration in gastric
cancer cells. J Cancer Res Clin Oncol. 139:1033–1042. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zha L, Zhang J, Tang W, Zhang N, He M, Guo
Y and Wang Z: HMGA2 elicits EMT by activating the Wnt/β-catenin
pathway in gastric cancer. Dig Dis Sci. 58:724–733. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weng J, Xiao J, Mi Y, Fang X, Sun Y, Li S,
Qin Z, Li X, Liu T, Zhao S, et al: PCDHGA9 acts as a tumor
suppressor to induce tumor cell apoptosis and autophagy and inhibit
the EMT process in human gastric cancer. Cell Death Dis. 9:272018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Zhang N, Wang Y, Xu M, Liu N, Pang
X, Cao J, Ma N, Pang H, Liu L and Zhang H: Zinc finger E-box
binding homeobox 1 promotes invasion and bone metastasis of small
cell lung cancer in vitro and in vivo. Cancer Sci. 103:1420–1428.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao S, Wang J and Xiao N: MicroRNAs as
noninvasive biomarkers in bladder cancer detection: A diagnostic
meta-analysis based on qRT-PCR data. Int J Biol Markers.
31:e276–e285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
Kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fernandez-Pol S, Ma L, Ohgami RS and Arber
DA: Immunohistochemistry for p53 is a useful tool to identify cases
of acute myeloid leukemia with myelodysplasia-related changes that
are TP53 mutated, have complex karyotype, and have poor prognosis.
Mod Pathol. 30:382–392. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Loboda A, Nebozhyn MV, Watters JW, Buser
CA, Shaw PM, Huang PS, Van't Veer L, Tollenaar RA, Jackson DB,
Agrawal D, et al: EMT is the dominant program in human colon
cancer. BMC Med Genomics. 4:92011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pei Z, Du X, Song Y, Fan L, Li F, Gao Y,
Wu R, Chen Y, Li W, Zhou H, et al: Down-regulation of lncRNA CASC2
promotes cell proliferation and metastasis of bladder cancer by
activation of the Wnt/β-catenin signaling pathway. Oncotarget.
8:18145–18153. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao MX, Jiang YP, Tang YL and Liang XH:
The crosstalk between lncRNA and microRNA in cancer metastasis:
Orchestrating the epithelial-mesenchymal plasticity. Oncotarget.
8:12472–12483. 2017.PubMed/NCBI
|
|
29
|
Zheng Y, Song D, Xiao K, Yang C, Ding Y,
Deng W and Tong S: LncRNA GAS5 contributes to lymphatic metastasis
in colorectal cancer. Oncotarget. 7:83727–83734. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li L, Zhang L, Zhang Y and Zhou F:
Increased expression of LncRNA BANCR is associated with clinical
progression and poor prognosis in gastric cancer. Biomed
Pharmacother. 72:109–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hang Q, Sun R, Jiang C and Li Y: Notch 1
promotes cisplatin-resistant gastric cancer formation by
upregulating lncRNA AK022798 expression. Anticancer Drugs.
26:632–640. 2015.PubMed/NCBI
|
|
32
|
Zamani M, Sadeghizadeh M, Behmanesh M and
Najafi F: Dendrosomal curcumin increases expression of the long
non-coding RNA gene MEG3 via up-regulation of epi-miRs in
hepatocellular cancer. Phytomedicine. 22:961–967. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng W, Si S, Zhang Q, Li C, Zhao F, Wang
F, Yu J and Ma R: Long non-coding RNA MEG3 functions as a competing
endogenous RNA to regulate gastric cancer progression. J Exp Clin
Cancer Res. 34:792015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu B, Shen ED, Liao MM, Hu YB, Wu K, Yang
P, Zhou L and Chen WD: Expression and mechanisms of long non-coding
RNA genes MEG3 and ANRIL in gallbladder cancer. Tumour Biol.
37:9875–9886. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang M, Huang T, Luo G, Huang C, Xiao XY,
Wang L, Jiang GS and Zeng FQ: Long non-coding RNA MEG3 induces
renal cell carcinoma cells apoptosis by activating the
mitochondrial pathway. J Huazhong Univ Sci Technolog Med Sci.
35:541–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qin R, Chen Z, Ding Y, Hao J, Hu J and Guo
F: Long non-coding RNA MEG3 inhibits the proliferation of cervical
carcinoma cells through the induction of cell cycle arrest and
apoptosis. Neoplasma. 60:486–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wei S, Wang L, Zhang L, Li B, Li Z, Zhang
Q, Wang J, Chen L, Sun G, Li Q, et al: ZNF143 enhances metastasis
of gastric cancer by promoting the process of EMT through PI3K/AKT
signaling pathway. Tumour Biol. 37:12813–12821. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Feng S, Zheng Z, Feng L, Yang L, Chen Z,
Lin Y, Gao Y and Chen Y: Proton pump inhibitor pantoprazole
inhibits the proliferation, self-renewal and chemoresistance of
gastric cancer stem cells via the EMT/β-catenin pathways. Oncology
Rep. 36:3207–3214. 2016. View Article : Google Scholar
|
|
40
|
Chen G, Tang N, Wang C, Xiao L, Yu M, Zhao
L, Cai H, Han L, Xie C and Zhang Y: TNF-α-inducing protein
ofi induces epithelial-mesenchymal transition (EMT) in
gastric cancer cells through activation of IL-6/STAT3 signaling
pathway. Biochem Biophys Res Commun. 484:311–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
